CordenPharma Invests €80M to Reach 500M Sterile Injectable Units
Image
Basel – September 15, 2026 -- CordenPharma is committing €80 million in multi-year capital expenditure to expand aseptic fill-finish capacity at its FDA- and EMA-approved Caponago site near Milan, targeting total production capacity of up to 500 million sterile injectable units annually.
New 11,000-square-meter facility adds over 50% to site footprint
A key milestone within the total investment was the €13 million acquisition of a new 11,000 m2 commercial building and an adjacent 26,000 m2 plot next to the existing advanced-phase fill-finish area. The expansion, completed July 28, 2026, increases the facility's overall footprint by more than 50%.